1. Home
  2. AG vs MYGN Comparison

AG vs MYGN Comparison

Compare AG & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Majestic Silver Corp. (Canada)

AG

First Majestic Silver Corp. (Canada)

HOLD

Current Price

$19.41

Market Cap

10.8B

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$3.80

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AG
MYGN
Founded
1979
1991
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
444.2M
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
AG
MYGN
Price
$19.41
$3.80
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$21.92
$7.64
AVG Volume (30 Days)
11.9M
1.6M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
0.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
$24.41
$6.86
Revenue Next Year
$10.68
$5.45
P/E Ratio
$143.01
N/A
Revenue Growth
N/A
2.33
52 Week Low
$5.83
$3.53
52 Week High
$32.00
$8.59

Technical Indicators

Market Signals
Indicator
AG
MYGN
Relative Strength Index (RSI) 42.87 39.20
Support Level $18.32 N/A
Resistance Level $23.54 $5.30
Average True Range (ATR) 1.24 0.26
MACD -0.23 -0.03
Stochastic Oscillator 13.44 17.55

Price Performance

Historical Comparison
AG
MYGN

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is in the business of production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. The company owns four producing mines in Mexico, consisting of the Santa Elena Silver/Gold Mine, the San Dimas Silver/Gold Mine, the Los Gatos Silver Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA. Additionally, the firm holds interests in the San Martin Silver Mine and the Del Toro Silver Mine, and several exploration-stage projects. The majority of the company's revenues are from the sale of precious metals contained in dore and concentrate form. It generates maximum revenue from the sale of silver, followed by gold, zinc, copper, and other metals.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: